Döhner H - Search Results

1

A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations.

Fiedler W, Kayser S, Kebenko M, Janning M, Krauter J, Schittenhelm M, Götze K, Weber D, Göhring G, Teleanu V, Thol F, Heuser M, Döhner K, Ganser A, Döhner H, Schlenk RF. Fiedler W, et al. Among authors: dohner k, dohner h. Br J Haematol. 2015 Jun;169(5):694-700. doi: 10.1111/bjh.13353. Epub 2015 Mar 29. Br J Haematol. 2015. PMID: 25818407 Free article. Clinical Trial.

2

Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia.

Fröhling S, Skelin S, Liebisch C, Scholl C, Schlenk RF, Döhner H, Döhner K; Acute Myeloid Leukemia Study Group, Ulm. Fröhling S, et al. Among authors: dohner k, dohner h. J Clin Oncol. 2002 May 15;20(10):2480-5. doi: 10.1200/JCO.2002.08.155. J Clin Oncol. 2002. PMID: 12011125

3

Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.

Döhner K, Tobis K, Ulrich R, Fröhling S, Benner A, Schlenk RF, Döhner H. Döhner K, et al. Among authors: dohner h. J Clin Oncol. 2002 Aug 1;20(15):3254-61. doi: 10.1200/JCO.2002.09.088. J Clin Oncol. 2002. PMID: 12149299 Clinical Trial.

4

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

Fröhling S, Schlenk RF, Breitruck J, Benner A, Kreitmeier S, Tobis K, Döhner H, Döhner K; AML Study Group Ulm. Acute myeloid leukemia. Fröhling S, et al. Among authors: dohner k, dohner h. Blood. 2002 Dec 15;100(13):4372-80. doi: 10.1182/blood-2002-05-1440. Epub 2002 Aug 8. Blood. 2002. PMID: 12393388 Free article.

5

Up-front randomization and common standard arm: a proposal for comparing AML treatment strategies between different studies.

Büchner T, Döhner H, Ehninger G, Ganser A, Hasford J; German AML Inter-group. Büchner T, et al. Among authors: dohner h. Leuk Res. 2002 Dec;26(12):1073-5. doi: 10.1016/s0145-2126(02)00084-x. Leuk Res. 2002. PMID: 12443878

6

Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia.

Vollmer M, Li L, Schmitt A, Greiner J, Reinhardt P, Ringhoffer M, Wiesneth M, Döhner H, Schmitt M. Vollmer M, et al. Among authors: dohner h. Br J Haematol. 2003 Mar;120(6):1000-8. doi: 10.1046/j.1365-2141.2003.04212.x. Br J Haematol. 2003. PMID: 12648070 Free article.

7

Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.

Scholl C, Breitinger H, Schlenk RF, Döhner H, Fröhling S, Döhner K; AML Study Group Ulm. Scholl C, et al. Among authors: dohner k, dohner h. Genes Chromosomes Cancer. 2003 Nov;38(3):274-80. doi: 10.1002/gcc.10284. Genes Chromosomes Cancer. 2003. PMID: 14506704

8

Mutation analysis of the transcription factor PU.1 in younger adults (16 to 60 years) with acute myeloid leukemia: a study of the AML Study Group Ulm (AMLSG ULM).

Döhner K, Tobis K, Bischof T, Hein S, Schlenk RF, Fröhling S, Döhner H. Döhner K, et al. Among authors: dohner h. Blood. 2003 Nov 15;102(10):3850; author reply 3850-1. doi: 10.1182/blood-2003-08-2654. Blood. 2003. PMID: 14597609 Free article. No abstract available.

9

Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.

Krauter J, Gorlich K, Ottmann O, Lubbert M, Dohner H, Heit W, Kanz L, Ganser A, Heil G. Krauter J, et al. Among authors: dohner h. J Clin Oncol. 2003 Dec 1;21(23):4413-22. doi: 10.1200/JCO.2003.03.166. J Clin Oncol. 2003. PMID: 14645432

10

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.

Fröhling S, Schlenk RF, Stolze I, Bihlmayr J, Benner A, Kreitmeier S, Tobis K, Döhner H, Döhner K. Fröhling S, et al. Among authors: dohner k, dohner h. J Clin Oncol. 2004 Feb 15;22(4):624-33. doi: 10.1200/JCO.2004.06.060. Epub 2004 Jan 15. J Clin Oncol. 2004. PMID: 14726504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

687 results

Search Page

Filters